Effective Management of Hemoptysis Via Endobronchial Application of Ankaferd Hemostat
ARCHIVOS DE BRONCONEUMOLOGIA, vol.50, no.9, pp.407-409, 2014 (SCI-Expanded, Scopus)
- Publication Type: Article / Article
- Volume: 50 Issue: 9
- Publication Date: 2014
- Doi Number: 10.1016/j.arbres.2013.12.007
- Journal Name: ARCHIVOS DE BRONCONEUMOLOGIA
- Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
- Page Numbers: pp.407-409
- Keywords: Hemoptysis, Endobronchial application, Liquid hemostatic agent, Ankaferd hemostat
- Ondokuz Mayıs University Affiliated: Yes
Abstract
Hemoptysis is symptomatic of potentially serious and life-threatening chest disease and requires urgent evaluation and treatment. The aim of this study was to evaluate the hemostatic efficacy of endobronchial application of Ankaferd Blood Stopper (R) (ABS) solution in patients with hemoptysis.